Brachytherapy Monotherapy in the SBRT Era: Still the Gold Standard To Beat?

As SBRT continues to reshape the treatment of localized prostate cancer, brachytherapy remains one of the most established forms of ultra-hypofractionated radiation therapy. This webinar will review updated contemporary evidence supporting LDR and HDR brachytherapy monotherapy, including patient selection, fractionation, disease control, and toxicity. We will explore the evolving role of brachytherapy monotherapy as it remains the gold standard for the treatment of localized prostate cancer.

Speakers:
Marjory Jolicoeur, MD, Hôpital Charles LeMoyne
Dan Krauss, MD, Corewell Health
Peter Rossi, MD, FABS, Calaway - Young Cancer Center at Valley View Hospital 

Moderator:
Lara Hathout, MD, Rutgers Cancer Institute

Why are you seeing "Registration not available?"
This message appears because you are not currently logged into your ABS account. To proceed seamlessly with your registration, please make sure you are logged in. If you are new to ABS, you will first need to create a record. Once logged in, you’ll have full access to the registration features without interruption.

After logging in:
Once you’ve clicked “Register Myself,” be sure to select “Add to your Calendar” on the next screen. This places the event directly on your calendar and sets your reminder automatically, so the session is already saved well before the ABS Zoom link is sent out closer to the date.

After adding the event to your calendar:
Don’t forget to click “Proceed to Checkout” to complete your registration. This final step ensures your enrollment is confirmed and your spot in the webinar is secured.